CLYM•globenewswire•
Climb Bio to Present at Upcoming Investor Conferences
Summary
WELLESLEY HILLS, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed below.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 5, 2026 by globenewswire